Effects of Microbial Metabolites of (-)-Epigallocatechin Gallate on Glucose Uptake in L6 Skeletal Muscle Cell and Glucose Tolerance in ICR Mice.
AMP-Activated Protein Kinases
/ metabolism
Animals
Blood Glucose
/ metabolism
Catechin
/ analogs & derivatives
Cell Line
Gastrointestinal Microbiome
Glucose
/ metabolism
Glucose Tolerance Test
Hypoglycemic Agents
Lactones
/ metabolism
Male
Mice
Mice, Inbred ICR
Muscle Fibers, Skeletal
/ drug effects
Myoblasts, Skeletal
/ drug effects
Phosphorylation
Signal Transduction
/ drug effects
glucose tolerance
glucose transporter 4
metabolite
tea catechin
γ-valerolactone
Journal
Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
5
2
2019
pubmed:
5
2
2019
medline:
10
7
2019
Statut:
ppublish
Résumé
Glucose uptake ability into L6 skeletal muscle cell was examined with eleven kinds of ring fission metabolites of (-)-epigallocatechin gallate (EGCG) produced by intestinal bacteria. The metabolites 5-(3,5-dihydroxyphenyl)-γ-valerolactone (EGC-M5), 4-hydroxy-5-(3,4,5-trihydroxyphenyl)valeric acid (EGC-M6), 5-(3,4,5-trihydroxyphenyl)-γ-valerolactone (EGC-M7) and 5-(3-hydroxyphenyl)valeric acid (EGC-M11) have been found to promote uptake of glucose into L6 myotubes significantly. EGC-M5, which is one of the major ring fission metabolites of EGCG, was also found to have a promotive effect on glucose transporter 4 (GLUT4) translocation accompanied by phosphorylation of AMP-activated protein kinase (AMPK) signaling pathway in skeletal muscle both in vivo and in vitro. Furthermore, the effect of oral single dosage of EGC-M5 on glucose tolerance test with ICR mice was examined and significant suppression of hyperglycemia was observed. These data suggested that EGC-M5 has an antidiabetic effect in vivo.
Identifiants
pubmed: 30713253
doi: 10.1248/bpb.b18-00612
doi:
Substances chimiques
5-(3,5-dihydroxyphenyl)-gamma-valerolactone
0
Blood Glucose
0
Hypoglycemic Agents
0
Lactones
0
Catechin
8R1V1STN48
epigallocatechin gallate
BQM438CTEL
AMP-Activated Protein Kinases
EC 2.7.11.31
Glucose
IY9XDZ35W2
gamma-valerolactone
O7056XK37X
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM